We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
35 result(s) found, displaying 21 to 30
-
Prescription medicine registrationActive ingredients: DTPa5-HB-IPV-Hib.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Eslicarbazepine acetate
-
-
Prescription medicine registrationActive ingredients: eslicarbazepine acetate.
-
Cancellation by sponsorRequested by Maxx Pharma Pty Ltd
-
Cancellation by sponsorRequested by Maxx Pharma Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Opicapone
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OGIVRI trastuzumab (rch) 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FULPHILA pegfilgrastim 6 mg/0.6 mL pre-filled syringe.